Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery

Surgery for Obesity and Related Diseases

Volumn 10, Issue 1, 2014, Pages 1-8

  Campos, Guilherme M ^a,b   Rabl, Charlotte ^a,b,c   Havel, Peter J ^d   Rao, Madhu ^b   Schwarz, Jean Marc ^e   Schambelan, Morris ^b   Mulligan, Kathleen ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

Bariatric surgery; C peptide; Free fatty acids; Gastric bypass; Glucagon; Glucose; Gut hormones; Hyperinsulinemic euglycemic clamp; Incretins; Insulin clearance; Insulin resistance; Type 2 diabetes

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; INSULIN; PANCREAS HORMONE; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN CLEARANCE; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; STEADY STATE; STOMACH BYPASS; CALORIC INTAKE; CALORIC RESTRICTION; ENDOCRINE PANCREAS FUNCTION TEST; EUGLYCEMIC HYPERINSULINEMIC CLAMP; FOLLOW UP; HYPERINSULINEMIA; MEAL TOLERANCE TEST; MIDDLE AGED; MORBID OBESITY; WEIGHT REDUCTION;

BARIATRIC SURGERY; C-PEPTIDE; FREE FATTY ACIDS; GASTRIC BYPASS; GLUCAGON; GLUCOSE; GUT HORMONES; HYPERINSULINEMIC EUGLYCEMIC CLAMP; INCRETINS; INSULIN CLEARANCE; INSULIN RESISTANCE; TYPE 2 DIABETES;

BLOOD GLUCOSE; CALORIC RESTRICTION; FATTY ACIDS, NONESTERIFIED; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY, MORBID; PANCREATIC HORMONES; POSTOPERATIVE CARE; POSTPRANDIAL PERIOD; WEIGHT LOSS;

EID: 84893733642     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2013.07.010     Document Type: Article

References (32)

1. H. Buchwald, R. Estok, and K. Fahrbach et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 2009 248 256
2. E. Ferrannini, and G. Mingrone Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes Diabetes Care 32 2009 514 520
3. M. Salehi, B. Aulinger, R.L. Prigeon, and D.A. D'Alessio Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes Diabetes 59 2010 1330 1337
4. R. Morinigo, R. Casamitjana, and S. Delgado et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects Diabetes Care 30 2007 1906 1908
5. F. Rodieux, V. Giusti, D.A. D'Alessio, M. Suter, and L. Tappy Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release Obesity (Silver Spring) 16 2008 298 305
6. C.H. Anderwald, A. Tura, and M. Promintzer-Schifferl et al. Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery Diabetes Care 35 2012 2580 2587
7. S.H. Jacobsen, S.C. Olesen, and C. Dirksen et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects Obes Surg 22 2012 1084 1096
8. J.M. Ramon, S. Salvans, and X. Crous et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial J Gastrointest Surg 16 2012 1116 1122
9. T.B. Curry, S.K. Roberts, and R. Basu et al. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals Am J Physiol Endocrinol Metab 300 2011 E746 E751
10. G.M. Campos, C. Rabl, and S. Peeva et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost J Gastrointest Surg 14 2010 15 23
11. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
12. M. Deitel, K. Gawdat, and J. Melissas Reporting weight loss 2007 Obes Surg 17 2007 565 568
13. B. Laferrere Effect of gastric bypass surgery on the incretins Diabetes Metab 35 2009 513 517
14. R.R. Henry, L. Scheaffer, and J.M. Olefsky Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 61 1985 917 925
15. M.W. Schwartz, and R.J. Seeley Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss N Engl J Med 336 1997 1802 1811
16. J.M. Schwarz, R.A. Neese, S. Turner, D. Dare, and M.K. Hellerstein Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection J Clin Invest 96 1995 2735 2743
17. K.F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R.E. Hendler, and G.I. Shulman Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 2005 603 608
18. J. Ma, C.K. Rayner, K.L. Jones, and M. Horowitz Insulin secretion in healthy subjects and patients with type 2 diabetes - role of the gastrointestinal tract Best Pract Res Clin Endocrinol Metab 23 2009 413 424
19. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
20. J.J. Holst, and J. Gromada Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans Am J Physiol Endocrinol Metab 287 2004 E199 E206
21. N.B. Jorgensen, S.H. Jacobsen, and C. Dirksen et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance Am J Physiol Endocrinol Metab 303 2012 E122 E131
22. M.M. Swarbrick, K.L. Stanhope, and I.T. Austrheim-Smith et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery Diabetologia 51 2008 1901 1911
23. Y. Falken, P.M. Hellstrom, J.J. Holst, and E. Naslund Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides J Clin Endocrinol Metab 96 2011 2227 2235
24. B. Laferrere, N. Swerdlow, and B. Bawa et al. Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes J Clin Endocrinol Metab 95 2010 4072 4076
25. P.J. Havel, and G.J. Taborsky Jr The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress Endocr Rev 10 1989 332 350
26. A. Kotronen, A. Seppala-Lindroos, R. Bergholm, and H. Yki-Jarvinen Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome Diabetologia 51 2008 130 138
27. C. Rabl, and G.M. Campos The impact of bariatric surgery on nonalcoholic steatohepatitis Semin Liver Dis 32 2012 80 91
28. A. Kotronen, L. Juurinen, M. Tiikkainen, S. Vehkavaara, and H. Yki-Jarvinen Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes Gastroenterology 135 2008 122 130
29. A. Kotronen, S. Vehkavaara, A. Seppala-Lindroos, R. Bergholm, and H. Yki-Jarvinen Effect of liver fat on insulin clearance Am J Physiol Endocrinol Metab 293 2007 E1709 E1715
30. B.P. Cummings, K.L. Stanhope, and J.L. Graham et al. Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2 DM rats Diabetes 59 2010 2653 2661
31. N.A. Gupta, J. Mells, and R.M. Dunham et al. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway Hepatology 51 2010 1584 1592
32. G. Svegliati-Baroni, S. Saccomanno, and C. Rychlicki et al. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis Liver Int 31 2011 1285 1297